Biotech

All Articles

Metsera join Amneal to lock down GLP-1 supply

.With very early phase 1 records now out in the wild, metabolic condition attire Metsera is actually...

Rivus posts data to support muscle-sparing weight problems medication insurance claims

.Rivus Pharmaceuticals has actually introduced the records responsible for its own period 2 obesity ...

BMS pays out $110M to create T-cell treatment deal, assisting Best buy time to improve prioritized pipe

.Bristol Myers Squibb is paying Prime Medication $110 million beforehand to cultivate reagents for e...

Generate increases an additional $1B-plus Big Pharma relationship

.Novartis has inked a package likely worth greater than $1 billion with Flagship-founded Generate: B...

Metsera GLP-1 data cut reveals 7.5% weight loss at 36 days

.Recently debuted Metsera is unfolding some phase 1 record for its own GLP-1 receptor agonist, expos...

Flagship really hopes biotechs flock to Mirai to boost genetic medications

.Among the genetic medications arms ethnicity, Crown jewel Pioneering is actually introducing a bran...

BioAge eyes $180M coming from IPO, exclusive placement for excessive weight tests

.BioAge Labs is eyeing all around $180 thousand in preliminary proceeds coming from an IPO and also ...

Merck's LAG-3 combo neglects colon cancer cells stage 3 study

.An effort through Merck &amp Co. to open the microsatellite steady (MSS) metastatic colorectal canc...

Spanish VC closes $200M lifestyle sciences fund

.Spain-based Asabys Allies has actually closed a fund of 180 thousand euros ($ 200 million), funds t...

BioAge generates $198M coming from IPO as being overweight biotech joins Nasdaq

.BioAge Labs is generating practically $200 thousand by means of its Nasdaq IPO today, along with th...